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Abstract: We investigated whether the
activity of double-stranded RNA activated
kinase (p68/PKR) is necessary for induction of
IDO (indolamine 2,3 –dioxygenase) gene by
IFN-γ. For this purpose, we planned to
abrogate the function of cellular wt-PKR
gene. Clones of ME180 cells expressing the
dominant negative form of PKR were selected
in the presence of neomycin. Then these cells
were treated with IFN-γ and accumulation of

1

Department of Biology, Faculty of Art and
2
Science, Departments of
Pathology,
3
Surgery, Faculty of Medicine, Akdeniz
4
University, Antalya, Turkey
Indiana
University, Medical School, Cancer Research
Center, Indianapolis, Indiana, USA

Introduction
Interferon was discovered as an antiviral agent during
studies on viral interference. Viral infection of eucaryotic
cells causes early and transient expression of various
cytokine and chemokine genes that constitute a crucial
step in stimulation of interferon (IFN) genes and the
subsequent activation of other genes stimulated by IFNs.
There are two groups of IFNs. Type I IFNs are IFN-α and
–β, type II interferon is IFN-γ. Type I IFNs are produced
by leucocyte and fibroblast, respectively, in response to
virus infection, whereas type II IFN is produced by natural
killer cells and T-cells in response to mitogenic or
antigenic stimuli (1,2).
Released interferons show their effects by binding to
specific receptors on the cell surface. While IFN-α and -β
bind to the same receptor and induce activation of similar
sets of genes, IFN-γ binds to different receptors and
induces activation of different sets of genes. IFN-γ
receptor is composed of two subunits, IFNGR1, 2. IFN-γ
binding to its receptor induces heterodimerization of the
receptor (3,4). JAK1 and JAK2 tyrosine kinases bind to
heterodimerized
receptors
and
subsequently
phosphorylate latent cytoplasmic transcription factors,
STATs. Phosphorylated forms of STATs translocate to the
nucleus and bind to cis-acting elements, designated the
gamma-activated sequence, GAS, that is commonly found
in IFN-γ-inducible genes, such as IDO (Indolamine 2,3dioxygenase), GBP (Guanylate Binding protein), MHC-I,II

IDO protein was determined by Western blot
analysis. We found that clones expressing the
dominant negative form of the PKR gene
were not only resistant to IFN-γ-mediated
killing, but were also incapable of inducing
accumulation of IDO protein after IFN-γ
treatment.
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(Major Histocompability Complex) and IRF-1 (Interferon
Regulatory Factor-1) (5-10).
PKR is an IFN-inducible, dsRNA-dependent protein
kinase (11,12). In IFN-treated cells, PKR is found
predominantly in the cytoplasm and is associated with
ribosomes; however, small amounts of PKR have also
been shown in the nucleus (13). PKR is activated by
autophosphorylation after binding to dsRNA, heparin,
chondrotin sulfate and poly I: C, all of which exhibit an
anionic character. Following activation, PKR catalyzes the
intermolecular phosphorylation of at least six protein
substrates: the PKR protein itself, the α-subunit of eIF-2,
the IkB, the Tat protein of HIV, the NFAT, and MPP4
(14). Protein synthesis initiation factor 2, factor eIF-2, is
the best characterized PKR substrate so far.
Phosphorylation of eIF-2 by PKR leads to an inhibition of
translation by impairing the eIF-2B-catalyzed guanine
nucleotide exchange reaction (15). In addition to playing
a role in IFN’s action, PKR is also implicated in the control
of cell proliferation (16,17).
Indoleamin-2,3-dioxygenase is one the best known
IFN-γ inducible genes. The product of IDO gene degrades
cellular tryptophan into kynurenin and formylkynurenin
and this causes cell death because of tryptophan
starvation. This is one of the best known mechanisms
explaining the antiviral and antiproliferative effects of
IFN-γ (10,18,19).
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Several studies have established that changes in
protein phosphorylation mediated by PKR play an
important role in the antiviral action as well as the
inhibition of cell proliferation mediated by IFNs. In this
regard, we have previously shown that IFN-γ induces
phosphorylation of this kinase. We have also shown that
IFN-γ-mediated induction of IDO transcription was
suppressed in the presence of PKR inhibitor, 2aminopurine (10).
In this study, we used a genetic approach to further
investigate the involvement of PKR activity in IFN-γmediated induction of IDO gene transcription as well as in
IFN-γ-mediated cytotoxicity. We used an eucaryotic
expression vector expressing a dominant negative allele of
PKR, which was previously used and claimed to have
tumor suppressor function (16,17). We found that both
activities of IFN-γ can be ablated by overexpression of the
dominant negative form of PKR in the IFN-γ sensitive
human cervical carcinoma cell line, ME180.

Materials and Methods
Cell Culture and Transfection
Cell line, ME180 (human cervical carcinoma cell line),
plasmid carrying the dominant negative form of PKR and
antibodies to IDO and GAPDH were provided by Milton
W. Taylor (Indiana University, Bloomington,
Indiana/USA). ECL and PVDF membrane were purchased
from Amersham, USA. All the chemicals used for
electrophoresis were purchased from Sigma. Cells were
grown in DMEM (D-5280, Sigma) medium supplemented
with 10% FCS (fetal calf serum) and 1% AntibioticAntimycotic solution, at 37 °C in 5% CO2 medium.
Plasmid was transfected into ME180 cells by calciumphosphate transfection and neomycin-resistant clones
were selected in medium containing 400µg/ml of
neomycin.
Cytotoxicity Assay
ME180 cells were grown until they completely
covered the bottom of 96-well plates. Cells were treated
with various doses of IFN-γ. Treated cells were incubated
for 72 hours at 37 °C in humidified 5% CO2 atmosphere.
Following incubation, floating cells were removed and
attached cells were stained with crystal violet (0.5% in
methanol) and dye absorbed by live cells was extracted
with sodium citrate (0.1 M) in 50% ethanol. Absorbance
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was read at 600 nm. Absorbance values of samples were
normalized to that of untreated cells to obtain percentage
cytotoxicity.
Western Blot Analysis
Cell extract was prepared in Triton X-100 buffer (50
mM Hepes pH: 7.0, 150 mM NaCl, 10% glycerol, 1 mM
MgCl2, 1 mM EDTA, 1.2% Triton X-100). Amount of
protein was determined and electrophoresis was
performed by loading a 100 µg protein sample into each
well. Proteins were then blotted onto nitrocellulose
membrane in transfer buffer (3.75 g glycin, 7.25 g Tris
base, 2.5 ml methanol was dissolved in total 2.5 liters) at
4 °C. The membranes were incubated in 5% fat-free milk
solution prepared in PBST buffer (1X PBS pH: 7.0, 1 ml
Tween-20/liter) at room temperature for 2 hours and
then primary antibodies were added over an additional
hour in 1: 5000 dilution for IDO and 1: 50000 for
GAPDH. Once the primary antibody labeling was
performed, the blots were washed with PBST for an hour
at room temperature. Secondary antibody labeling was
performed at room temperature for one hour at 1: 5000
dilution in 5% fat-free milk in PBST. After one hour of
washing at room temperature with PBST, ECL reagents
were used to visualize proteins.

Results
Expression of the Dominant Negative Form of PKR
Gene Inhibits IFN-γ-Mediated Cytotoxicity
Cells expressing the dominant negative form of PKR
gene were selected in the presence of neomycin, and then
these cells were tested for IFN-γ sensitivity along with
wild type ME180 cells. As shown in Figure 1, normal
ME180 cells treated with IFN-γ displayed very high death
rates with increasing IFN-γ concentrations, while the
clones expressing the dominant negative form of PKR
showed very little sensitivity to IFN-γ, indicating the fact
that activity of PKR is necessary for IFN-γ to show its
cytotoxic effects on these cells.
Dominant Negative Form of PKR Inhibits IFN-γMediated Accumulation of IDO Protein
After determining the requirement of PKR activity for
IFN-γ-mediated killing of ME180 cells, we wanted to
determine whether PKR activity might be doing this by
affecting the induction of IDO protein accumulation. As
shown in Figure 2 (upper), wild type ME180 cells treated
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protects ME180 cells from IFN-γ-mediated cytotoxicity.
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in serum containing DMEM until they covered the bottom
of the wells. Then IFN-γ was added at different
concentrations and cells were further incubated in this
medium for an additional 72 hours. At the end of this
incubation period, dead cells were removed and attached
cells were stained with crystal violet for 1 hour, then cellabsorbed dye was eluted with sodium citrate buffer and
absorbance was read at 600 nm. Absorbance of treated
cells were divided by that of untreated control cells to
calculate percentage killing.
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IFN-γ-induced accumulation of IDO protein is impaired in
cells expressing the dominant negative mutant of PKR.
ME180 cells overexpressing the dominant negative mutant
of PKR were selected as described in the Materials and
Methods. Then the cells were treated with 500 Units/ml of
IFN-γ for different time periods and cell lysates were
collected in lysis buffer, and 100 µg of total proteins were
used for Western blotting. The blot was labeled with antiIDO antibody (upper), then stripped off and labeled with
anti-GAPDH antibody to show that each lane contained
equal amounts of protein (lower).

the basal transcription complex. These results clearly
indicate that the enzyme activity of PKR not only is
necessary for delivering the cytotoxic effect of IFN-γ, but
is also necessary for induction of accumulation of IDO
protein after IFN-γ treatment in ME180 cells.

IDO

Discussion

GAPDH

Figure 2.

IFN-γ induces the accumulation of IDO protein in a timedependent manner in MT-ME180 cells. ME 180 cells were
treated with 500 Units/ml of IFN-γ for different time periods
and cell lysates were collected in lysis buffer, and 100 µg
of total proteins were used for Western blotting. The blot
was labeled with anti-IDO antibody (upper), then stripped
off and labeled with anti-GAPDH antibody to show that
each lane contained equal amounts of protein (lower).

with 500 Unit/ml of IFN-γ showed significant
accumulation of IDO protein in a time-dependent manner.
However, the same amount of IFN-γ for the same time
period did not induce any IDO protein accumulation in
ME180 cells overexpressing the dominant negative form
of PKR (Figure 3 [upper]). However, overexpression of
the dominant negative PKR did not affect the activity of

In this study, we used dominant negative mutant form
PKR to investigate whether PKR activity is required for
IFN-γ-mediated induction of IDO gene. The results
indicate that enzymatic activity of the kinase is necessary
for IFN-γ to induce cytotoxicity as well as IDO induction in
the human cervical carcinoma cell line ME180.
Several lines of publications support the notion that
PKR may function through STAT transcription factors
(20). PKR is specifically associated with Stat 3 in several
cell types in response to PDGF, and PDGF-induced Stat 3
DNA-binding activity is deficient in cells derived from PKR
knock-out mice. It has been also shown that PKR is
upstream of MAP kinases, p38 and ERK 1/2 (21,22) and
these kinases were shown to be involved in the
phosphorylation of Serin 727 in Stat 1. Serin
phosphorylation is absolutely necessary for the
transactivation function of Stat 1. In addition to its
requirement for Stat 1, 3 and MAP kinase activation, PKR
was also shown to be necessary for the activation of
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transcription factor NF-kB by different stimuli (23,24).
In terms of the transcriptional induction of IDO gene
by IFN-γ, there are only two transcription factors claimed
to have roles in this process. We have shown that
interferon regulatory factor 1 (IRF1) is involved in this
process (18,25). Chon et al. claimed that both IRF1 and
Stat 1 cooperatively bind to the promoter of IDO gene
after IFN-γ treatment (26). No data providing evidence of
phosphorylation of these transcription factors by PKR has
been shown yet, but it is very likely that either
transcription factors can be a direct target of PKR.
However, given the fact that the activation of NF-kB and
Stat transcription factors requires the activity of PKR and
the activity of both transcription factors is essential for
transcriptional upregulation of IRF1 gene (14), we

strongly think that PKR activity is necessary for the
accumulation of IRF1 protein after IFN-γ treatment. In
fact, during preparation of this manuscript, Blair et al.
have shown that poly I: C and IFN-γ-mediated
accumulation of IRF1 is completely inhibited in PKR-/mouse cells (20).
Correspondence author:
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